Cargando…

The Efficacy and Safety of Compound Danshen Dripping Pill Combined with Percutaneous Coronary Intervention for Coronary Heart Disease

OBJECTIVE: Compound Danshen dripping pill (CDDP) is a well-known Chinese patent medicine, which is commonly used for the treatment of coronary heart disease (CHD) in China. This study is aimed at systematically assessing the clinical efficacy of CDDP for CHD patients. METHODS: Eight databases were r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Cailan, Li, Qian, Xu, Jiamin, Wu, Wenzhen, Wu, Yuling, Xie, Jianhui, Yang, Xiaobo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685822/ https://www.ncbi.nlm.nih.gov/pubmed/33281912 http://dx.doi.org/10.1155/2020/5067137

Ejemplares similares

Compound Danshen Dripping Pill Pretreatment to Prevent Contrast-Induced Nephropathy in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Yang, Rong, et al.
Publicado: (2014)

Recommendations on the Clinical Use of Compound Danshen Dripping Pills
Publicado: (2017)

Proangiogenesis effects of compound danshen dripping pills in zebrafish
por: Hu, Yang-Xi, et al.
Publicado: (2022)

Compound Danshen dripping pills in treating with coronary heart disease: A protocol for systematic review and meta-analysis
por: Sun, Ling, et al.
Publicado: (2022)

Compound Danshen Dripping Pill Inhibits Retina Cell Apoptosis in Diabetic Rats
por: Zhang, Qian, et al.
Publicado: (2018)

Metabonomic Strategy to the Evaluation of Chinese Medicine Compound Danshen Dripping Pills Interfering Myocardial Ischemia in Rats
por: Xin, Xue, et al.
Publicado: (2013)

Coadministration of Compound Danshen dripping pills and bezafibrate has a protective effect against diabetic retinopathy
por: Liu, Le, et al.
Publicado: (2022)

Therapeutic Efficacy and Safety of Safflower Injection in the Treatment of Acute Coronary Syndrome
por: Lu, Qiang, et al.
Publicado: (2021)

Pre-treatment with compound Danshen dripping pills prevents lipid infusion-induced microvascular dysfunction in mice
por: Zhang, Yanda, et al.
Publicado: (2020)

Compound danshen dripping pills modulate the perturbed energy metabolism in a rat model of acute myocardial ischemia
por: Guo, Jiahua, et al.
Publicado: (2016)

The Relationship between Compound Danshen Dripping Pills with Isosorbide Mononitrate in the Treatment of Elderly Patients with Unstable Angina Pectoris
por: Liang, Yulin, et al.
Publicado: (2018)

Compound danshen dripping pills vs. nitrates for stable angina pectoris: a systematic review and meta-analysis
por: Zhang, Mengying, et al.
Publicado: (2023)

Synergistic Effects of Clopidogrel and Fufang Danshen Dripping Pills by Modulation of the Metabolism Target and Pharmacokinetics
por: Ma, Shitang, et al.
Publicado: (2014)

Compound Danshen Dripping Pill for Treating Early Diabetic Retinopathy: A Randomized, Double-Dummy, Double-Blind Study
por: Luo, Dan, et al.
Publicado: (2015)

Compound Danshen Dripping Pill for Treating Nonproliferative Diabetic Retinopathy: A Meta-Analysis of 13 Randomized Controlled Trials
por: Huang, Wenjing, et al.
Publicado: (2017)

Compound Danshen Dripping Pill inhibits high altitude-induced hypoxic damage by suppressing oxidative stress and inflammatory responses
por: Hu, Yunhui, et al.
Publicado: (2021)

Compound Danshen Dripping Pill inhibits hypercholesterolemia/atherosclerosis-induced heart failure in ApoE and LDLR dual deficient mice via multiple mechanisms
por: Yang, Yanfang, et al.
Publicado: (2023)

Effects of compound Danshen dropping pills on adverse cardiovascular events and quality of life after percutaneous coronary intervention in patients with coronary heart disease: A protocol for systematic review and meta-analysis
por: Lv, Lina, et al.
Publicado: (2022)

Compound danshen dripping pills combined with trimetazidine in treating unstable angina pectoris: Protocol for a systematic review of randomized controlled trials
por: Yao, Dongfeng, et al.
Publicado: (2019)

Systematic review and Meta-analysis of 26 randomized controlled clinical trials of Compound Danshen Dripping Pill for non-proliferating diabetic retinopathy
por: Wang, Yu, et al.
Publicado: (2021)

Compound Danshen Dripping Pills Prevented Leptin Deficiency-Induced Hepatic ER Stress, Stimulated Autophagy, and Improved Insulin Resistance of ob/ob Mice
por: Shi, Yanan, et al.
Publicado: (2020)

Musk Tongxin Dripping Pills for treating Ticagrelor in Patients After Percutaneous Coronary Intervention: Echocardiography Combined with Untargeted Metabolomics
por: Nan, Lyu, et al.
Publicado: (2021)

Protective effect of compound Danshen (Salvia miltiorrhiza) dripping pills alone and in combination with carbamazepine on kainic acid-induced temporal lobe epilepsy and cognitive impairment in rats
por: Jia, Chen, et al.
Publicado: (2018)

Effectiveness and Safety of Fufang Danshen Dripping Pill (Cardiotonic Pill) on Blood Viscosity and Hemorheological Factors for Cardiovascular Event Prevention in Patients with Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis
por: Wi, Minji, et al.
Publicado: (2023)

Danshen (Salvia miltiorrhiza) Compounds Improve the Biochemical Indices of the Patients with Coronary Heart Disease
por: Liu, Boyan, et al.
Publicado: (2016)

Compound danshen dripping pills normalize a reprogrammed metabolism of myocardial ischemia rats to interpret its time-dependent efficacy in clinic trials: a metabolomic study
por: Aa, Nan, et al.
Publicado: (2019)

Efficacy and Safety of Shexiang Baoxin Pill for Coronary Heart Disease after Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis
por: Wei, Jingjing, et al.
Publicado: (2021)

Efficacy of INtensive Treatment vs. Standard Treatment of COmpound DanshEn Dripping Pills in Refractory Angina Patients With Incomplete Revascularization (INCODER Study): Study Protocol for a Multicenter, Double-Blind, Randomized Controlled, Superiority Trial
por: Wu, Zexuan, et al.
Publicado: (2022)

A Review of Danshen Combined with Clopidogrel in the Treatment of Coronary Heart Disease
por: Zhang, Zhaojian, et al.
Publicado: (2019)

A Study Protocol for a Randomized, Double-Blind, Placebo-Controlled Clinical Study on the Effect of Qishen Yiqi Dripping Pills on Exercise Endurance and Quality of Life in Patients with Coronary Heart Disease after Percutaneous Coronary Intervention
por: Yu, Linghua, et al.
Publicado: (2021)

Effect of various Danshen injections on patients with coronary heart disease after percutaneous coronary intervention: A protocol for a systematic review and network meta-analysis
por: Zhu, Zehao, et al.
Publicado: (2018)

Systematic Review of Compound Danshen Dropping Pill: A Chinese Patent Medicine for Acute Myocardial Infarction
por: Luo, Jing, et al.
Publicado: (2013)

Elucidating direct kinase targets of compound Danshen dropping pills employing archived data and prediction models
por: Wang, Tongxing, et al.
Publicado: (2021)

Efficacy and Safety of Qishen Yiqi Dripping Pill for Heart Failure With Preserved Ejection Fraction: A Systematic Review and Meta-Analysis
por: Wang, Mengxi, et al.
Publicado: (2021)

Mechanisms and Molecular Targets of Compound Danshen Dropping Pill for Heart Disease Caused by High Altitude Based on Network Pharmacology and Molecular Docking
por: Yan, Jiayi, et al.
Publicado: (2021)

Evaluation and clinical implications of interactions between compound Danshen dropping pill and warfarin associated with the epoxide hydrolase gene
por: Chen, Xixi, et al.
Publicado: (2023)

Mechanism of tanshinones and phenolic acids from Danshen in the treatment of coronary heart disease based on co-expression network
por: Wu, Dongxue, et al.
Publicado: (2020)

The Clinical Pharmacokinetics and Pharmacodynamics of Warfarin When Combined with Compound Danshen: A Case Study for Combined Treatment of Coronary Heart Diseases with Atrial Fibrillation
por: Lv, Chunxiao, et al.
Publicado: (2017)

Investigating the molecular mechanism of Compound Danshen Dropping Pills for the treatment of epilepsy by utilizing network pharmacology and molecular docking technology
por: Huang, Dan, et al.
Publicado: (2022)

Evaluating the efficacy and safety of percutaneous coronary intervention (PCI) versus the optimal drug therapy (ODT) for stable coronary heart disease: a systematic review and meta-analysis
por: Qian, Xiaodong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nem150epve3isnj243r93g8eed